Skip to main content
. 2021 May 3;105(1):24–30. doi: 10.4269/ajtmh.21-0007

Table 3.

Summary of studies identifying risk factors or predictors of AKI among dengue patients

Reference Population age (years) AKI incidence N (%) Risk factors/predictors Adjusted OR P value
Laoprasopwattana et al.7 < 15 25/2,893 (0.9) DSS 16.9 (4.2–68.5) < 0.01
Obesity 6.3 (1.4–28.8) < 0.01
Basu and Roy29 < 14 13/97 (13.4) DHF/DSS
Age < 5 yo
Lee et al.17 > 18 10/304 (3.3) DSS 220.0 (19.80–2,443.89) < 0.001
Mehra et al.26 All ages 24/223 (10.8) Elevated ALT and ALP
Hypoalbuminemia
Metabolic acidosis
Coexisting viral hepatitis
Sepsis
MODS
Inotropic drug use
Mallhi et al.8 ≥ 12 95/667 (14.2) Male 2.7 (1.25–5.99) 0.012
DHF 8.0 (3.64–17.59) < 0.001
Rhabdomyolysis 7.9 (3.04–20.49) < 0.001
MODS 17.9 (9.14–35.12) < 0.001
Diabetes mellitus 4.7 (1.12–19.86) 0.034
Late hospitalization 2.1 (1.06–4.13) 0.033
Nephrotoxic drug use 2.9 (1.34–6.11) 0.006
Khalil et al.20 > 14 71/532 (13.3) Male 4.43 (1.92–10.23) < 0.001
DHF/DSS 2.14 (1.06–4.32) 0.03
Neurological involvement 12.08 (2.82–51.77) 0.001
Prolonged aPTT 1.81 (1.00–3.26) 0.04
Diptyanusa et al.22 ≥ 18 71/1,484 (4.8) Older age 1.30 (1.03–1.64) 0.027
Male 3.49 (1.75–6.95) < 0.001
Diabetes mellitus 2.89 (1.05–7.93) 0.039
Obesity 1.94 (1.00–3.77) 0.049
Severe dengue 5.45 (2.47–12.04) < 0.001
Coexisting bacterial infection 6.15 (2.57–14.74) < 0.001
Patel et al.49 > 14 90/620 (16.4) Male 2.9 (1.28–5.89) 0.015
DHF 7.9 (3.69–18.60) < 0.001
Rhabdomyolysis 8.2 (3.14–21.52) < 0.001
MODS 18.2 (9.24–36.24) < 0.001
Diabetes mellitus 4.8 (1.15–18.97) 0.051
Delayed hospitalization 2.2 (1.07–4.23) 0.032
Nephrotoxic drug use 2.86 (1.36–6.22) 0.005

AKI = acute kidney injury; ALT = alanine aminotransferase; ALP = alkaline phosphatase; aPTT = activated partial thromboplastin time; DHF = dengue hemorrhagic fever; DSS = dengue shock syndrome; MODS = multiple organ dysfunction syndrome; OR = odds ratio.